Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 195 citing articles:

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, Kerstin Kläser, Anna May, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 7, pp. 939-949
Open Access | Times Cited: 986
Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
Stella Talic, Shivangi Shah, Holly Wild, et al.
BMJ (2021), pp. e068302-e068302
Open Access | Times Cited: 632
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, et al.
The Lancet (2021) Vol. 397, Iss. 10282, pp. 1351-1362
Open Access | Times Cited: 624
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
Eleftheria Vasileiou, Colin R Simpson, Ting Shi, et al.
The Lancet (2021) Vol. 397, Iss. 10285, pp. 1646-1657
Open Access | Times Cited: 563
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 530
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
Ross Harris, Jennifer Hall, Asad Zaidi, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 8, pp. 759-760
Open Access | Times Cited: 371
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
Tal Brosh‐Nissimov, Efrat Orenbuch‐Harroch, Michal Chowers, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1652-1657
Open Access | Times Cited: 337
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers
Yaniv Lustig, Einav Sapir, Gili Regev‐Yochay, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 9, pp. 999-1009
Open Access | Times Cited: 330
Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Lucie Loyal, Julian Braun, Larissa Henze, et al.
Science (2021) Vol. 374, Iss. 6564
Open Access | Times Cited: 275
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie Ewer, Ane Ogbe, et al.
The Lancet HIV (2021) Vol. 8, Iss. 8, pp. e474-e485
Open Access | Times Cited: 233
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
Giulia Giordano, Marta Colaneri, Alessandro Di Filippo, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 993-998
Open Access | Times Cited: 201
COVID-19 in long-term care
Eileen Rocard, Paola Sillitti, Ana Llena‐Nozal
OECD health working papers (2021)
Open Access | Times Cited: 163
Thrombosis after covid-19 vaccination
Paul R. Hunter
BMJ (2021), pp. n958-n958
Closed Access | Times Cited: 132
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Matthew J. Gorman, Nita Patel, Mimi Guebre‐Xabier, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 9, pp. 100405-100405
Open Access | Times Cited: 129
Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality
César G. Victora, Márcia C. Castro, Susie Gurzenda, et al.
EClinicalMedicine (2021) Vol. 38, pp. 101036-101036
Open Access | Times Cited: 122
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 3, pp. 398-404
Open Access | Times Cited: 120
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
Helen Parry, Graham McIlroy, Rachel Bruton, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 115
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know
Gowthami M. Arepally, Thomas L. Ortel
Blood (2021) Vol. 138, Iss. 4, pp. 293-298
Open Access | Times Cited: 107
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose
Yaniv Lustig, Tal Gonen, Lilac Meltzer, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 940-946
Open Access | Times Cited: 92
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, et al.
Vaccine (2021) Vol. 39, Iss. 22, pp. 2995-3006
Open Access | Times Cited: 97
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Raphael Sonabend, Lilith K. Whittles, Natsuko Imai, et al.
The Lancet (2021) Vol. 398, Iss. 10313, pp. 1825-1835
Open Access | Times Cited: 93
The success of SARS-CoV-2 vaccines and challenges ahead
Kanta Subbarao
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 87
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France
Tiffany Charmet, Laura Schaeffer, Rebecca Grant, et al.
The Lancet Regional Health - Europe (2021) Vol. 8, pp. 100171-100171
Open Access | Times Cited: 82
Extended interval BNT162b2 vaccination enhances peak antibody generation in older people
Helen Parry, Rachel Bruton, Christine Stephens, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top